The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity.
作者： Richard Beasley , Grace Bird , James Harper , Mark Weatherall
DOI: 10.1183/13993003.00694-2018
关键词:
摘要: A paradigm shift in asthma management that addresses the paradoxes of SABA reliever therapy is required; consideration needs to be given replacement with ICS/fast-onset β-agonist across range severityhttp://ow.ly/ccff30lNLPv
sci-hub.se 参考文章(34)
ANNE E. TATTERSFIELD, DIRKJE S. POSTMA, PETER J. BARNES, KLAS SVENSSON, CARL-AXEL BAUER, PAUL M. O'BYRNE, CLAES-GÖRAN LÖFDAHL, ROMAIN A. PAUWELS, ANDERS ULLMAN, Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. American Journal of Respiratory and Critical Care Medicine. ,vol. 160, pp. 594- 599 ,(1999) , 10.1164/AJRCCM.160.2.9811100
Monica Fletcher, David Hiles, Continuing discrepancy between patient perception of asthma control and real-world symptoms: a quantitative online survey of 1,083 adults with asthma from the UK Primary Care Respiratory Journal. ,vol. 22, pp. 431- 438 ,(2013) , 10.4104/PCRJ.2013.00091
LESLIE N. GAY, CLINICAL EVALUATION OF ISOPROPYLEPINEPHRINE IN MANAGEMENT OF BRONCHIAL ASTHMA Journal of the American Medical Association. ,vol. 139, pp. 452- 457 ,(1949) , 10.1001/JAMA.1949.72900240003008
R. Beasley, H. Windom, N. Pearce, C. Burgess, J. Crane, Asthma mortality and inhaled beta agonist therapy Australian and New Zealand Journal of Medicine. ,vol. 21, pp. 753- 763 ,(1991) , 10.1111/J.1445-5994.1991.TB01385.X
E A Mitchell, Is current treatment increasing asthma mortality and morbidity Thorax. ,vol. 44, pp. 81- 84 ,(1989) , 10.1136/THX.44.2.81
Mitesh Patel, Janine Pilcher, Alison Pritchard, Kyle Perrin, Justin Travers, Dominick Shaw, Shaun Holt, Matire Harwood, Peter Black, Mark Weatherall, Richard Beasley, Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial The Lancet Respiratory Medicine. ,vol. 1, pp. 32- 42 ,(2013) , 10.1016/S2213-2600(13)70007-9
J KRAAN, G KOETER, T MARK, H SLUITER, K DEVRIES, Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline The Journal of Allergy and Clinical Immunology. ,vol. 76, pp. 628- 636 ,(1985) , 10.1016/0091-6749(85)90786-9
Alberto Papi, Brunilda Marku, Nicola Scichilone, Piero Maestrelli, Pierluigi Paggiaro, Marina Saetta, Stefano Nava, Ilenia Folletti, Giuseppina Bertorelli, Stefano Bertacco, Marco Contoli, Mario Plebani, Maria Pia Foschino Barbaro, Antonio Spanevello, Maria Aliani, Marco Pannacci, Paolo Morelli, Bianca Beghé, Leonardo M Fabbri, Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial The Lancet Respiratory Medicine. ,vol. 3, pp. 109- 119 ,(2015) , 10.1016/S2213-2600(14)70266-8
Olof Selroos, Anne Pietinalho, Ann-Britt Löfroos, Henrik Riska, Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma Chest. ,vol. 108, pp. 1228- 1234 ,(1995) , 10.1378/CHEST.108.5.1228
Brian J. O'Connor, Sarah L. Aikman, Peter J. Barnes, Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. The New England Journal of Medicine. ,vol. 327, pp. 1204- 1208 ,(1992) , 10.1056/NEJM199210223271704